Validation of a serum screen for Alzheimer’s disease across assay platforms, species and tissues

Sid E. O’Bryant,Guanghua Xiao,Fan Zhang,Melissa Edwards,Dwight C. German,Xiangling Yin,Tori Como,Joan S. Reisch,Ryan M. Huebinger,Neill R. Graff-Radford,Dennis W. Dickson,Robert Barber,James R. Hall,Padraig O'Suilleabhain,Paula Grammas

Validation of a serum screen for Alzheimer’s disease across assay platforms, species and tissues

2014

Sid E. O’Bryant
Guanghua Xiao
Fan Zhang
Melissa Edwards
Dwight C. German
Xiangling Yin
Tori Como
Joan S. Reisch
Ryan M. Huebinger
Neill R. Graff-Radford
Dennis W. Dickson
Robert Barber
James R. Hall
Padraig O'Suilleabhain
Paula Grammas

Background There is a significant need for rapid and cost-effective biomarkers of Alzheimer’s disease (AD) for advancement of clinical practice and therapeutic trials.

Keywords:

Clinical Practice
Biomarker (medicine)
Immunology
Alzheimer's disease
Disease
Biology
Pathology
Microvessel
Blood proteins
serum samples
meso scale
primary care

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations